Studies
|
56,011 |
|
Biosamples
|
183,990 |
|
Sequencing Projects
|
508,073 |
|
Analysis Projects
|
381,503 |
| Organisms | 480,513 |
| PROJECT INFORMATION | |
|---|---|
|
GOLD Project ID
|
Gp0004333
|
|
Project Name
|
Lachnoclostridium cf. saccharolyticum K10
|
|
Other Names
|
|
|
Legacy ER Project ID
|
14580
|
|
Legacy GOLD ID
|
Gi04078, Gc01475
|
| NCBI BioProject Name | Clostridium cf. saccharolyticum K10 |
|
NCBI BioProject Accession
|
PRJEA45855 |
|
NCBI Locus Tag
|
CLS
|
|
NCBI BioSample Accession
|
|
|
Source Sample ID
|
|
| PI | Turner K |
| Added By | Heather Creasy on 2009-02-14 |
| Last Modified By | Supratim Mukherjee on 2018-06-05 |
| Project Comments |
|
|
Project Status
|
Complete and Published
|
|
Project Relevance
|
Human Microbiome Project (HMP) Medical |
|
Sequencing Center
|
Wellcome Trust Sanger Institute
(United Kingdom)
|
|
Collaborating Institute
|
|
|
Funding Agency
|
European Union (EU)
(European Union)
|
|
Project Description
|
Clostridium cf. saccharolyticum K10 genome sequencing project
|
| Is JGI Project |
No
|
|
Project Information Visibility
|
Public |
| PROJECT TYPE | |
|
Specimen
|
Organism |
|
Nucleic Acid
|
DNA |
|
Sequencing Strategy
|
Whole Genome Sequencing
|
| EXTERNAL PROJECT LINKS | |
|
JGI Data Utilization Status
|
|
|
JGI Award DOI
|
|
|
Genome Publications
|
|
|
Other Publications
|
|
|
Ignored Publications
|
|
|
Unassigned Publications
|
Applied and environmental microbiology: 74(12):3915-7 Transfer of conjugative elements from rumen and human Firmicutes bacteria to Roseburia inulinivorans. PubMed: 18456856 DOI: 10.1128/AEM.02807-07 Antimicrobial agents and chemotherapy: 45(11):3246-9 Novel tetracycline resistance gene, tet(32), in the Clostridium-related human colonic anaerobe K10 and its transmission in vitro to the rumen anaerobe Butyrivibrio fibrisolvens. PubMed: 11600392 Show more publications...
Antimicrobial agents and chemotherapy: 50(8):2632-9 Comparative analysis of sequences flanking tet(W) resistance genes in multiple species of gut bacteria.
PubMed: 16870752 |
| SRA Experiment |
|
| PROJECT COMPOSITION | |
| Study |
Human Microbiome Project (HMP) Reference Genomes |
| Organism |
Lachnoclostridium cf. saccharolyticum K10 |
| Analysis Projects |
Lachnoclostridium cf. saccharolyticum K10 |
| Number of Analysis Projects (AP) |
1 |
| Number of Derived Analyis Projects (DAP) |
0
|
| SEQUENCING INFORMATION | |
|---|---|
|
Sequencing Status
|
Complete |
| Sequencing Quality (MIGS-31) |
Level 6: Finished |
|
Finishing Goal
|
|
|
Contamination Screening Input
|
|
|
DNA Amplification Method
|
|
|
Single Cell Lysis Protocol
|
|
|
Single Cell Lysis Approach
|
|
|
Sequencing Comments
|
|
|
DNA Amplification Kit
|
|
|
Sequencing Technology
(MIGS-29)
|
454 |
|
Library Method
(MIGS-28)
|
|
|
Library Layout
|
|
|
Library Screening Method
|
|
|
Number Of Reads
|
|
|
Read Size
|
|
|
Vector
|
|
| GC Percent |
50
|
| Chromosome Count |
1
|
| Plasmid Count |
0
|
| ORGANISM NAME | |
|---|---|
| GOLD Organism ID |
Go0004333 |
| Organism Name |
Lachnoclostridium cf. saccharolyticum K10
|
| Other names (alias, synonyms, short names, common names) |
Clostridium cf. saccharolyticum K10
|
| Organism Domain |
BACTERIAL
|
| Phylogeny |
FIRMICUTES
|
| Genus |
Lachnoclostridium
|
| Genus Synonyms |
Clostridium
|
| Species |
Lachnoclostridium cf. saccharolyticum
|
| Subspecies |
|
| Species Synonyms |
|
| Strain |
K10
|
| Strain Synonyms |
|
| Serovar/Cultivar |
|
| Culture Collection ID |
|
| Type Strain |
Unknown
|
| Exemplar DOI |
|
| Exemplar Name |
|
| Taxon DOI |
|
| Biosafety Level |
|
| Organism Comments |
|
| Cultured |
Yes
|
| Culture Type |
Isolate
|
| Organism Type |
Natural
|
| Uncultured Type |
|
| Commercial Strain |
|
| Commercial Strain Comments |
|
|
ORGANISM TAXONOMY
|
|
| NCBI Taxonomy ID |
717608 |
| NCBI Superkingdom |
Bacteria
|
| NCBI Kingdom |
|
| NCBI Phylum |
Firmicutes
|
| NCBI Class |
Clostridia
|
| NCBI Order |
Eubacteriales
|
| NCBI Family |
Lachnospiraceae
|
| NCBI Genus |
Lacrimispora
|
| NCBI Species |
Lacrimispora saccharolytica
|
| ISOLATION CLASSIFICATION | |
| Ecosystem |
Engineered
|
| Ecosystem Category |
Lab synthesis
|
| Ecosystem Type |
Unclassified
|
| Ecosystem Subtype |
Unclassified
|
| Specific Ecosystem |
Unclassified
|
| ORGANISM EXTERNAL REFERENCES | |
| Strain Info ID |
|
| Genbank 16S ID |
|
| GENERAL PROPERTIES | |
|---|---|
| Oxygen Requirement |
Anaerobe
|
| Cell Shape |
Rod-shaped
|
| Motility |
Motile
|
| Sporulation |
Sporulating
|
| Temperature Range |
Mesophile
|
| Salinity |
|
| pH |
|
| Cell Diameter |
|
| Cell Length |
|
| Color |
|
| Gram Staining |
Gram+
|
| Biotic Relationships | Free living |
| Symbiotic Physical Interaction |
|
| Symbiotic Relationship |
|
| Symbiont Name |
|
| Symbiont Taxon ID |
|
| Cell Arrangements |
Singles Pairs Chains |
| Diseases |
Botulism |
| Known Habitats |
Marine Host Food |
| Metabolisms |
|
| Phenotypes |
Pathogen |
| Energy Sources |
Chemoorganotroph |
| HMP METADATA | |
|---|---|
| HMP ID |
931
|
| Show in DACC? |
Yes
|
| HMP Project Status |
Complete
|
| BEI Status |
|
| NCBI Submission Status |
6. annotation (and sequence) public on NCBI site
|
| Isolate Suggestion Source |
|
| HMP Isolation Body Sample Site |
Gastrointestinal tract
|
| HMP Isolation Body Sample Subsite |
Gut
|
| HMP Finishing Goal |
|
| Source, Sample & Medical Relevance Comments |
|
| Isolate Availability Comments |
|
| Project Comments |
|
| DNA Received |
|
| Date DNA Received |
|
| Date Sequencing Begins |
|
| Date Draft Sequencing Completed |
|
| Cross Reference ID |
|
You are going to add the following user to your project, biosample and study.
Contact Name/Email: Do you want to continue?
You are going to remove permissions for the following user to your project, biosample and study.
Contact Name/Email: Do you want to continue?
Changing the SP visibility will also change visibility on the following items:
Do you want to continue with this visibility change?
Checking that this Sequencing Project can be made private:
Do you want to continue with this visibility change?
Changing the SP Sequencing Strategy will also effect these items:
Do you want to continue with this Sequencing Strategy change?
